检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Bimekizumab Maintains Improvements in Efficacy Endpoints and Has a Consistent Safety Profile Through 52 Weeks in Patients with Non-Radiographic Axial Spondyloarthritis and Ankylosing Spondylitis: Results from Two Parallel Phase 3 Studies

Xenofon Baraliakos,Atul Deodhar,Desiree van der Heijde,Marina Magrey,Walter Maksymowych,Tetsuya Tomita,Huji Xu,Marga Oortgiesen,Ute Massow,Carmen Fleurinck,Alicia M. Ellis, Tom Vaux,Julie Shepherd-Smith,Alexander Marten,Lianne S. Gensler

ARTHRITIS & RHEUMATOLOGY（2022）

引用 0|浏览5
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要